vaccine

What is the significance of the World Health Organization's approval of the R21/Matrix-M malaria vaccine

The World Health Organization (WHO) has recently approved the use of the R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India, which incorporates Novavax's adjuvant technology.